Modulation of tumour infiltrating lymphocyte activity by the H2 antagonist, cimetidine

Modulation of tumour infiltrating lymphocyte activity by the H2 antagonist, cimetidine [ 1998 - 2000 ]

Also known as:

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/980256]

Researchers: Prof David Morris (Principal investigator)

Funding Amount $AUD 127,483.28

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph

Subjects

Identifiers